Cingulate Inc. (CING)
NASDAQ: CING · Real-Time Price · USD
6.27
-0.22 (-3.39%)
At close: Feb 27, 2026, 4:00 PM EST
6.45
+0.18 (2.87%)
After-hours: Feb 27, 2026, 7:05 PM EST
Cingulate Market Cap
Cingulate has a market cap or net worth of $65.32 million as of February 27, 2026. Its market cap has increased by 337.70% in one year.
Market Cap
65.32M
Enterprise Value
63.78M
1-Year Change
337.70%
Ranking
Category
Stock Price
$6.27
Market Cap Chart
Since the IPO on December 8, 2021, Cingulate's market cap has increased from $64.29M to $65.32M, an increase of 1.62%. That is a compound annual growth rate of 0.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 65.32M | 122.75% |
| Dec 31, 2025 | 29.33M | 80.15% |
| Dec 31, 2024 | 16.28M | 127.09% |
| Dec 29, 2023 | 7.17M | -36.62% |
| Dec 30, 2022 | 11.31M | -63.77% |
| Dec 31, 2021 | 31.21M | -51.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XBiotech | 68.90M |
| Coeptis Therapeutics Holdings | 68.36M |
| ETHZilla | 67.11M |
| Grace Therapeutics | 66.38M |
| NeurAxis | 63.92M |
| Entera Bio | 63.74M |
| Q32 Bio | 63.71M |
| InflaRx | 62.33M |